What is the mechanism of action for selective serotonin reuptake inhibitors (SSRIs)?

What is the mechanism of action for selective serotonin reuptake inhibitors (SSRIs)?

• A. Inhibition of dopamine reuptake
• B. Inhibition of serotonin reuptake in the synaptic cleft
• C. Activation of serotonin receptors
• D. Inhibition of norepinephrine reuptake

Answer: (B)

Selective serotonin reuptake inhibitors (SSRIs) primarily function by inhibiting the reuptake of serotonin in the synaptic cleft. This means that when serotonin is released from the presynaptic neuron into the synaptic cleft, SSRIs block the transporters responsible for reabsorbing serotonin back into the presynaptic neuron. As a result, serotonin remains in the synaptic cleft longer, which enhances its availability to bind to postsynaptic receptors. This increased serotonin signaling is thought to improve mood and is a key reason why SSRIs are commonly prescribed to treat depression and anxiety disorders. The other options do not accurately describe the mechanism of action for SSRIs. For instance, while dopamine reuptake inhibitors impact dopamine levels, this is not the target for SSRIs. SSRIs also do not activate serotonin receptors directly; their primary action occurs before receptor activation by prolonging serotonin presence in the synapse. Lastly, norepinephrine reuptake inhibition is characteristic of other classes of antidepressants, such as SNRIs (serotonin-norepinephrine reuptake inhibitors), not SSRIs.

Selective serotonin reuptake inhibitors (SSRIs) primarily function by inhibiting the reuptake of serotonin in the synaptic cleft. This means that when serotonin is released from the presynaptic neuron into the synaptic cleft, SSRIs block the transporters responsible for reabsorbing serotonin back into the presynaptic neuron. As a result, serotonin remains in the synaptic cleft longer, which enhances its availability to bind to postsynaptic receptors. This increased serotonin signaling is thought to improve mood and is a key reason why SSRIs are commonly prescribed to treat depression and anxiety disorders.

The other options do not accurately describe the mechanism of action for SSRIs. For instance, while dopamine reuptake inhibitors impact dopamine levels, this is not the target for SSRIs. SSRIs also do not activate serotonin receptors directly; their primary action occurs before receptor activation by prolonging serotonin presence in the synapse. Lastly, norepinephrine reuptake inhibition is characteristic of other classes of antidepressants, such as SNRIs (serotonin-norepinephrine reuptake inhibitors), not SSRIs.